Revive Therapeutics Ltd. (CSE:RVV)
0.0150
-0.0050 (-25.00%)
Mar 31, 2025, 12:33 PM EST
Revive Therapeutics Statistics
Total Valuation
CSE:RVV has a market cap or net worth of CAD 6.28 million. The enterprise value is 6.22 million.
Market Cap | 6.28M |
Enterprise Value | 6.22M |
Important Dates
The next estimated earnings date is Wednesday, May 28, 2025.
Earnings Date | May 28, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
CSE:RVV has 418.56 million shares outstanding. The number of shares has increased by 15.37% in one year.
Current Share Class | n/a |
Shares Outstanding | 418.56M |
Shares Change (YoY) | +15.37% |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 1.51% |
Owned by Institutions (%) | 0.00% |
Float | 412.24M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | 0.98 |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -1.18 |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.06
Current Ratio | 0.06 |
Quick Ratio | 0.02 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -398.31 |
Financial Efficiency
Return on equity (ROE) is -66.49% and return on invested capital (ROIC) is -22.73%.
Return on Equity (ROE) | -66.49% |
Return on Assets (ROA) | -16.18% |
Return on Invested Capital (ROIC) | -22.73% |
Return on Capital Employed (ROCE) | -45.15% |
Revenue Per Employee | n/a |
Profits Per Employee | -2.65M |
Employee Count | 2 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -20.00% in the last 52 weeks. The beta is 0.27, so CSE:RVV's price volatility has been lower than the market average.
Beta (5Y) | 0.27 |
52-Week Price Change | -20.00% |
50-Day Moving Average | 0.01 |
200-Day Moving Average | 0.01 |
Relative Strength Index (RSI) | 59.07 |
Average Volume (20 Days) | 253,644 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -2.92M |
Pretax Income | -5.29M |
Net Income | -5.29M |
EBITDA | -2.92M |
EBIT | -2.92M |
Earnings Per Share (EPS) | -0.01 |
Balance Sheet
The company has 55,415 in cash and n/a in debt, giving a net cash position of 55,415 or 0.00 per share.
Cash & Cash Equivalents | 55,415 |
Total Debt | n/a |
Net Cash | 55,415 |
Net Cash Per Share | 0.00 |
Equity (Book Value) | 6.39M |
Book Value Per Share | 0.02 |
Working Capital | -3.04M |
Cash Flow
Operating Cash Flow | -2.60M |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
CSE:RVV does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -15.37% |
Shareholder Yield | -15.37% |
Earnings Yield | -84.33% |
FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |